James A. Schoeneck
Net Worth

Last updated:

What is James A. Schoeneck net worth?

The estimated net worth of Mr. James A. Schoeneck is at least $4,094,915 as of 7 Jun 2023. He owns shares worth $803,570 as insider, has earned $384,525 from insider trading and has received compensation worth at least $2,906,820 in FibroGen, Inc..

What is the salary of James A. Schoeneck?

Mr. James A. Schoeneck salary is $415,260 per year as Chairman in FibroGen, Inc..

How old is James A. Schoeneck?

Mr. James A. Schoeneck is 67 years old, born in 1958.

What stocks does James A. Schoeneck currently own?

As insider, Mr. James A. Schoeneck owns shares in one company:

Company Title Shares Price per share Total value
FibroGen, Inc. (FGEN) Chairman 73,722 $10.9 $803,570

What does FibroGen, Inc. do?

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China for anemia associated with myelodysplastic syndromes. It is also developing Pamrevlumab, a human monoclonal antibody that inhibits the activity of connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, liver fibrosis, and diabetic kidney disease, as well as Phase III trial for the treatment of Duchenne muscular dystrophy. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

FGEN logo
FGEN
FibroGen, Inc.
$10.9

James A. Schoeneck insider trading

FibroGen, Inc.

Mr. James A. Schoeneck has made 8 insider trades between 2018-2023, according to the Form 4 filled with the SEC. Most recently he sold 7,100 units of FGEN stock worth $127,985 on 7 Jun 2023.

The largest trade he's ever made was exercising 24,000 units of FGEN stock on 30 Oct 2018. As of 7 Jun 2023 he still owns at least 73,722 units of FGEN stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 7,100 $18.03 $127,985
Option
Common Stock 6,000 N/A N/A
Option
Stock Option (Right to Buy) 6,000 N/A N/A
Option
Common Stock 6,000 N/A N/A
Option
Stock Option (Right to Buy) 6,000 N/A N/A
Option
Common Stock 14,000 $3.2 $44,800
Option
Stock Option (Right to Buy) 2,000 $2.9 $5,800
Option
Common Stock 2,000 $2.9 $5,800
Option
Stock Option (Right to Buy) 2,000 $2.9 $5,800
Sale
Common Stock 2,000 $47.25 $94,490
Sale
Common Stock 2,000 $2.9 $5,800
Option
Common Stock 2,000 $2.9 $5,800
Option
Stock Option (Right to Buy) 2,000 $2.9 $5,800
Option
Stock Option (Right to Buy) 2,000 $2.9 $5,800
Option
Common Stock 2,000 $2.9 $5,800
Sale
Common Stock 2,000 $54.93 $109,850
Sale
Common Stock 2,000 $2.9 $5,800
Option
Common Stock 2,000 $2.9 $5,800
Option
Stock Option (Right to Buy) 2,000 $2.9 $5,800
Option
Stock Option (Right to Buy) 2,000 $2.9 $5,800
Sale
Common Stock 2,000 $2.9 $5,800
Option
Common Stock 2,000 $2.9 $5,800
Option
Stock Option (Right to Buy) 12,000 $9.78 $117,300
Option
Common Stock 24,000 $9.78 $234,600
Sale
Common Stock 7,639 $2.9 $22,153
Option
Common Stock 7,639 $2.9 $22,153
Option
Stock Option (Right to Buy) 7,639 $2.9 $22,153
Option
Common Stock 4,361 $2.9 $12,647
Sale
Common Stock 4,361 $2.9 $12,647
Option
Stock Option (Right to Buy) 4,361 $2.9 $12,647

FibroGen key executives

FibroGen, Inc. executives and other stock owners filed with the SEC: